Matsunaga, Akira

Impact of Lipoprotein Glomerulopathy on the Relationship Between Lipids and Renal Diseases

Saito, T., Matsunaga, A., & Oikawa, S. (2006) · American Journal of Kidney Diseases

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 96

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy

Matsunaga, A., Sasaki, J., Komatsu, T., Kanatsu, K., Tsuji, E., Moriyama, K., Koga, T., Arakawa, K., Oikawa, S., Saito, T., et al. (1999) · Kidney International

Lipid metabolism and disordersRenal Diseases and Glomerulopathies

Cited by 91

Apolipoprotein E–related glomerular disorders

Saito, T., Matsunaga, A., Fukunaga, M., Nagahama, K., Hara, S., & Muso, E. (2020) · Kidney International

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 77

Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy

Konishi, K., Saruta, T., Kuramochi, S., Oikawa, S., Saito, T., Han, H., Matsunaga, A., & Sasaki, J. (1999) · Nephron

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 54

A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy

Ando, M., Sasaki, J., Hua, H., Matsunaga, A., Uchida, K., Jou, K., Oikawa, S., Saito, T., & Nihei, H. (1999) · Kidney International

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 53

A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy

Kinomura, M., Sugiyama, H., Saito, T., Matsunaga, A., Sada, K.-E., Kanzaki, M., Takazawa, Y., Maeshima, Y., Yanai, H., & Makino, H. (2007) · Nephrology Dialysis Transplantation

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 40

Topics in lipoprotein glomerulopathy: an overview

Saito, T., Matsunaga, A., Ito, K., & Nakashima, H. (2014) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 33

Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia

Matsunaga, A., & Saito, T. (2014) · Clinical and Experimental Nephrology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 33

A Novel Mutation ApoE2 Kurashiki (R158P) in a Patient with Lipoprotein Glomerulopathy

Tokura, T., Itano, S., Kobayashi, S., Kuwabara, A., Fujimoto, S., Horike, H., Satoh, M., Komai, N., Tomita, N., Matsunaga, A., et al. (2011) · Journal of Atherosclerosis and Thrombosis

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 28

Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia

Matsunaga, A., Handa, K., Mori, T., Moriyama, K., Hidaka, K., Yuki, M., Sasaki, J., & Arakawa, K. (1992) · Atherosclerosis

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 23

Population frequency of apolipoprotein E5 (Glu3→Lys) and E7 (Glu244→Lys, Glu245→Lys) variants in western Japana

Matsunaga, A., Sasaki, J., Moriyama, K., Arakawa, F., Takada, Y., Nishi, K., Hidaka, K., & Arakawa, K. (1995) · Clinical Genetics

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 23

A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy

Toyota, K., Hashimoto, T., Ogino, D., Matsunaga, A., Ito, M., Masakane, I., Degawa, N., Sato, H., Shirai, S., Umetsu, K., et al. (2013) · Journal of Human Genetics

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 19

Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis

Saito, T., & Matsunaga, A. (2014) · Kidney International

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 18

A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate

Kodera, H., Mizutani, Y., Sugiyama, S., Miyata, T., Ehara, T., Matsunaga, A., & Saito, T. (2017) · Case Reports in Nephrology and Dialysis

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 17

Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 → Gln) in a hyperlipidemic patient with xanthomatosis

Moriyama, K., Sasaki, J., Takada, Y., Arakawa, F., Matsunaga, A., Ito, Y., & Arakawa, K. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 17

Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features

Matsunaga, A., & Saito, T. (2025) · Journal of Atherosclerosis and Thrombosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 14

Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2

Fukunaga, M., Nagahama, K., Aoki, M., Shimizu, A., Hara, S., Matsunaga, A., Muso, E., & Saito, T. (2018) · Case Reports in Nephrology and Dialysis

Renal Diseases and GlomerulopathiesSystemic Lupus Erythematosus Research

Cited by 14

A Rare Cause of Posttransplantation Nephrotic Syndrome

Foster, K., Matsunaga, A., Matalon, R., Saito, T., Gallo, G., D’Agati, V., & Stokes, M. B. (2005) · American Journal of Kidney Diseases

Renal Diseases and GlomerulopathiesRenal Transplantation Outcomes and Treatments

Cited by 14

A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes

Kato, T., Ushiogi, Y., Yokoyama, H., Hara, S., Matsunaga, A., Muso, E., & Saito, T. (2019) · CEN Case Reports

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 9

Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys)

Sasaki, M., Yasuno, T., Ito, K., Matsunaga, A., Hisano, S., Abe, Y., Miyake, K., Masutani, K., Nakashima, H., & Saito, T. (2018) · CEN Case Reports

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 9

A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka

Hirashima, H., Komiya, T., Toriu, N., Hara, S., Matsunaga, A., Saito, T., & Muso, E. (2018) · Clinical Nephrology – Case Studies

Renal Diseases and GlomerulopathiesSystemic Lupus Erythematosus Research

Cited by 8

Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy

Takasaki, S., Maeda, K., Joh, K., Yamakage, S., Fukase, S., Takahashi, T., Suzuki, M., Matsunaga, A., & Saito, T. (2015) · Case Reports in Nephrology and Dialysis

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 7

Significance of a Novel Apolipoprotein E Variant, ApoE Osaka/Kurashiki, in Lipoprotein Glomerulopathy

Saito, T., & Matsunaga, A. (2011) · Journal of Atherosclerosis and Thrombosis

Renal Diseases and GlomerulopathiesLipoproteins and Cardiovascular Health

Cited by 7

A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I

Takasaki, S., Matsunaga, A., Joh, K., & Saito, T. (2018) · CEN Case Reports

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 7